Pulmonary Embolism (duration) — MRCP Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Continue indefinite anticoagulation (extended-phase) at reduced DOAC dose
For unprovoked VTE and low bleeding risk, guidelines recommend indefinite anticoagulation; reduced-dose DOAC for extended phase is reasonable. Stopping at 3 months increases recurrence. Aspirin is inferior. IVC filter is not indicated when anticoagulation is possible.
Reference: CHEST Guideline (2021): Antithrombotic Therapy for VTE Disease